Could Moesin Be a New Marker for Indicating Progression in Endometrial Cancer?
Elif AğaçayakAysenur KelesUgur DegerMehmet Sirin OzcelikNurullah PekerReyhan GunduzMurat AkkusHuseyin BuyukbayramPublished in: Cancer management and research (2022)
Increased frequency of moesin expression in the preoperative period in patients with atypical hyperplasia should alert the surgeon in terms of malignancy. If the frequency of moesin expression increases in cases with endometrial cancer, the patient should be followed closely in terms of progression in the postoperative period.